15
Views
0
CrossRef citations to date
0
Altmetric
Review

The therapeutic potential of regulation of the Th1/Th2 balance

Pages 345-352 | Published online: 24 Feb 2005

Bibliography

  • ANDERSON MC: On Koch's treatment. Lancet (1891) 1:651–652.
  • WEINER HL, FRIEDMAN A, MILLER A, et al.: Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann. Rev. Immunol. (1994) 12:809–837.
  • GROUX H, O'GARRA A, BIGLER M, et al.: A CD4+ subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 389:737–742.
  • SHIRAKAWA T, ENOMOTO T, SHIMAZU S, HOPKIN JM: The inverse association between tuberculin responses and atopic disorder. Science (1996) 275:77–79.
  • ••A study of the effects of BCG vaccination and tuberculin positivity on atopy in 887 Japaneseschool children.
  • TURK JL, BRYCESON AD: Immunological phenomena in leprosy and related diseases.Adv. Immunol. (1971) 13:209–266.
  • •A classical review of what we now recognise as a Thl-Th2 spectrum in infectious disease.
  • HERNANDEZ-PANDO R, PA VON L, ARRIAGA K, et al.: Improvement and exacerbation of murine tuberculosis by previous exposure to low and high doses of an environmentalmycobacterial saprophyte. Infect. Immun. (1997) 65:3317–3327.
  • •An example of how manipulation of Thl /Th2 ratios can profoundly affect subsequent disease susceptibility.
  • SCHAUF V, ROM WN, SMITH KA, et al.: Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J. Infect. Dis. (1993) 168:1056–1059.
  • YONG AJ, GRANGE JM, TEE RD, et al.: Total and anti-mycobacterial IgE levels in serumfrom patients with tuberculosis and leprosy. Tubercle (1989) 70:273–279.
  • SCHOEDON G, GOLDENBERGER D, FORRER R, et al.: Deactivation of macrophages withIL-4 is the key to the isolation of Trophryma whippelii. J. Infect. Dis. (1997) 176:672–677.
  • •A study of the need to de-activate macrophages with IL-4 before growth of the organism that causes Whipple's disease can occur in these cells in vitro.
  • CLERICI M, SHEARER GM: A Thl-Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today (1993) 14:107–111.
  • ••The postulated switch to Th2 in HIV has remained controversial, but the hypothesis is clearlyset out.
  • KARP CL, VVYSOCKA M, WAHL LM, et al.: Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 273:228–231.
  • MARACK P, KAPPLER J: Subversion of the immune system by pathogens. Cell (1994) 76:323–332.
  • CLERICI M, ENRICO E, SHEARER GM: Tumour enhancement phenomenon: reinterpretation from a Thl/Th2 perspective. J. Natl. Cancer Inst. (1996) 88:461–462.
  • •A useful review of the data on Th2 responses in cancer, though there are now many more references to this point in other cancers.
  • DE REIJKE TM, DE BOER EC, KURTH KH, SCHAMHART DH: Urinary cytokines during intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value. J. Urol. (1996) 155:477–482.
  • PELLEGRINI P, BERGHELLA AM, DEL BEATO T, et al.: Dysregulation in Thl and Th2 subsets of CD4+ T-cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression. Cancer Immunol. Immunother. (1996) 42:1–8.
  • •A nice example of the switch to Th2 that commonly accompanies progressive cancer.
  • TSUKUI T, HILDESHEIM A, SCHIFFMAN MH, et al.: Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res. (1996) 56:3967–3974.
  • LEE KY, GOEDEGEBUURE PS, LINEHAN DC, EBERLEIN TJ: Immunoregulatory effects of CD4+ helper T-cells subsets in human melanoma. Surgery (1995) 117:365–372.
  • BRINKMANN V, KRISTOFIC C: Regulation by corticosteroids of Thl and Th2 cytokine production in human CD4+ effector T-cells generated from CD45R0- and CD45R0+ subsets. J. Immunol. (1995) 155:3322–3328.
  • RAMIREZ F, FOWELL DJ, PUKLAVEC M, SIMMONDS S, MASON D: Glucocorticoids promote a Th2 cytokine response by CD 4+ T-cells in vitro. J. Immunol. (1996) 156:2406–2412.
  • ••Elegant demonstration of the switching of newly recruited T-cells to Th2 by glucocorticoids.
  • STRACHAN DP, TAYLOR EM, CARPENTER RG: Family structure, neonatal infection, and hay fever in adolescence. Arch. Dis. Child. (1996) 74:422–426.
  • ••An epidemiological study indicating that childhood infections influence subsequentThl /Th2 balance.
  • SHAHEEN SO, AABY P, HALL AJ, et al.: Measles and atopy in Guinea-Bissau. Lancet (1996)347:1792–1796.
  • ROOK GAW, STANFORD JL: Give us this day our daily germs. Immunology Today (1998)19:113–116.
  • •A brief review of the possibility that the Western way of life is failing to provide the input that the immune system requires for correct regulation of Thl /Th2 balance, and of the activity of autoreactive T-cells.
  • AABY P: Assumptions and contradictions in measles and measles immunization research: is measles good for something Soc. Sci. Med. (1995) 41:673–686.
  • ••A fascinating review of the ways in which measles infection, or various different doses of thevaccine, can influence the incidence of atopy, and the susceptibility to quite unrelated diseases.
  • ROOK GAW, ZUMLA A: Gulf War Syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile Lancet (1997) 349:1831–1833.
  • VVYNN TA, CHEEVER AW, JANKOVIC D, et al.: An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature (1995) 376:594–596.
  • ••Evidence that by pre-empting the response to an antigenic component that usually evokes aTh2 response, and forcing it towards Thl, the pathogenesis of subsequent infection can be radically altered.
  • RAVEN PW, O'DVVYER AM, TAYLOR NF, CHECKLEY SA: The relationship between the effects of metyrapone treatment on depressed mood and urinary steroid profiles. Psychoneuroendocrinology (1996) 21:277–286.
  • HOLSBOER F, VON BARDELEBEN U, GERKEN A, STALLA GK, MULLER OA: Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. New. Engl. J. Med. (1984) 311:1127.
  • RUPPRECHT M, HORNSTEIN OP, SCHLUTER D, et al.: Cortisol, corticotropin, and beta-endorphin responses to corticotropin-releasing hormone in patients with atopic eczema. Psychoneuroendocrinology (1995) 20:543–551.
  • RAVEN PW, CHECKLEY SA, TAYLOR NF: Extra-adrenal effects of metyrapone include inhibition of 11-oxreductase activity of 11-beta-hydroxysteroid dehydrogenase: a model for 11-beta-HSD-1 deficiency. Clin. Endocrinol. (1995) 43:637–644.
  • LEB CR, HU F-Y, MURPHY BP: Metabolism of progesterone by human lymphocytes: production of neuroactive steroids. J. Clin. Endocrinol. Metab. (1997) 82:4064–4068.
  • •Still in its early days, but this paper suggests that T-cells may be a source of neuroactive steroids that can modulate mood, arousal and motor activity.
  • CHOUAIB S, ASSELIN-PATUREL C, MAMI-CHOUAIB F, CAIGNARD A, BLAY JY: The host tumour conflict: from immunosuppression to resistance and destruction. Immunol. Today (1997) 18:493–497.
  • ••A recent review of tumour immunology that stresses Thl /Th2 balance.
  • COWDERY JS, CHACE JH, YI AK, KRIEG AM: Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J. Immunol. (1996) 156:4570–4575.
  • KLINMAN DM, YI AK, BEAUCAGE SL, CONOVER J, KRIEG AM: CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA (1996) 93:2879–2883.
  • •Evidence that certain DNA sequences may have potential as cytokine modulating agents.
  • THOMPSON KA, STRAYER DR, SALVATO PD, et al.: Results of a double-blind, placebo-controlled study of the double-stranded RNA drug polyI:polyC 12U in the treatment of HIV infection. Eur. J. Clin. Microbiol. Infect. Dis. (1996) 15:580–587.
  • STRAYER DR, CARTER WA, BRODSKY Jet al.: A controlled clinical trial with a specifically configured RNA drug poly(I).poly(C12U) in chronic fatigue syndrome. Clin. Infect. Dis. (1994) 18\(Suppl. 1):S88–S95.
  • WANG CC, ROOK GAW: Inhibition of an established allergic response to ovalbumin in Balb/c mice by killed Mycobacterium vaccae. Immunology (1998) 93:307–313.
  • •Evidence that even a pre-existing Th2 response can be non-specifically down-regulated by a potent mycobacterial Thl-inducer.
  • ABOU-ZEID C, GARES M-P, INWALD J, et al.: Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae. Infect. Immun. (1997) 65:1856–1862.
  • SKINNER MA, YUAN S, PRESTIDGE R, et al.: Immunization with heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T-cells specific for macrophages infected with Mycobacterium tuberculosis. Infect. Immun. (1997) 65:4525–4530.
  • •There are few Thl adjuvants that also induce cytotoxic T-cells, but this preparation can do so. This paper needs to be considered together with the further information in [39].
  • SKINNER M, YUAN S, PRESTIDGE R, WATSON JD, TAN PLJ: Heat-killed mycobacterium vaccae as an adjuvant and vaccine for tuberculosis-stimulation of CD8+ cytotoxic T-cells. Vaccines beyond 2000. Queensland, Australia (6–9 July 1997). Abstract.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.